NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer.

NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer.

Item
http://www.wikidata.org/entity/Q54618824
The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer.Trastuzumab-Based Photoimmunotherapy Integrated with Viral HER2 Transduction Inhibits Peritoneally Disseminated HER2-Negative Cancer.Comparison of HER2 status by fluorescence in situ hybridisation and immunohistochemistry in gastric cancer.TEM7 (PLXDC1), a key prognostic predictor for resectable gastric cancer, promotes cancer cell migration and invasion.Beclin-1 expression is a significant predictor of survival in patients with lymph node-positive gastric cancer.HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma.Trastuzumab: a review of its use in HER2-positive advanced gastric cancer.Cost-effectiveness of precision medicine in gastrointestinal stromal tumor and gastric adenocarcinoma.
P2860

NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer.

Item
http://www.wikidata.org/entity/Q54618824
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
NICE guidance on trastuzumab f ...... ive metastatic gastric cancer.
@en
NICE guidance on trastuzumab f ...... ive metastatic gastric cancer.
@nl
type
label
NICE guidance on trastuzumab f ...... ive metastatic gastric cancer.
@en
NICE guidance on trastuzumab f ...... ive metastatic gastric cancer.
@nl
prefLabel
NICE guidance on trastuzumab f ...... ive metastatic gastric cancer.
@en
NICE guidance on trastuzumab f ...... ive metastatic gastric cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer
@en
P2093
P304
P31
P356
10.1016/S1470-2045(10)70276-X
P433
P478
P50
P577
P698